Locations:
Search IconSearch
November 9, 2017/Ophthalmology/News & Insight

Connect with Cole Eye Institute at AAO 2017

Presentations not to miss, beginning with Jackson Memorial Lecture, plus a lively booth

AAO 2017

Cleveland Clinic Cole Eye Institute will have a major presence at the American Association of Ophthalmology’s 2017 Annual Meeting. Join us at booth 5332 to discuss cases, trending topics and the day’s presentations with Cleveland Clinic Cole Eye Institute experts.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Cole Eye Institute chair delivers Jackson Memorial Lecture

Cole Eye Institute Chair Daniel F. Martin, MD, provides the institute’s and one of the annual meeting’s capstone presentations when he delivers the annual Jackson Memorial Lecture. Dr. Martin’s topic is “Evolution of Intravitreal Therapy for Retinal Diseases: From CMV to CNV.”

Dr. Martin has chaired Cleveland Clinic Cole Eye Institute since 2008 and holds the Barbara and A. Malachi Mixon III Institute Chair in Ophthalmology. Don’t miss Dr. Martin’s talk Sunday, Nov. 12, 9:30 a.m., at the Ernest N. Morial Convention Center Great Hall.

Cole Eye Institute presentations represent our leading-edge work in specialties including macular and retinal disease, refractive surgery, oculoplastics and orbital surgery, uveitis and intraocular inflammation, glaucoma, general medical ophthalmology, vision rehabilitation, neuro-ophthalmology and more.

Cole Eye Institute AAO presentations not to miss

Friday, Nov. 10

  • 4:06-4:36 p.m., (RET12): “Section IX: Late Breaking Developments – Part I,” The Great Hall, Andrew Schachat, MD

Saturday, Nov. 11

  • 2:53-3:02 p.m., (COR06): “Cornea 2017: Keeping the Old, or Breaking the Mold,” La Nouvelle Orleans AB, William Dupps, MD, PhD

Sunday, Nov. 12

  • 9:30 a.m., Jackson Memorial Lecture: “Evolution of Intravitreal Therapy for Retinal Diseases: From CMV to CNV,” Ernest N. Morial Convention Center Great Hall, Daniel F. Martin, MD
  • 10:12-10:19 a.m., (PA010): “Prospective, Double-Masked, Placebo-Controlled Phase 2b Trial on the Safety and Efficacy of ALG-1001 (Luminate) in Diabetic Macular Edema,” Room 255-257, Peter Kaiser, MD
  • 2-4:15 p.m., (234): “How to Evaluate a Patient with Uveitis,”(Cosponsored by Sociedad Panamericana de Enfermedades Inflamatorias Oculares of PAAO), Room 383-385, Careen Lowder, MD; Sunil Srivastava, MD

Advertisement

Monday, Nov. 13

  • 8:30-10 a.m., (SYM27): “Current Management of Neovascular AMD,” La Nouvelle Orleans, Peter Kaiser, MD; Daniel F. Martin, MD; Andrew Schachat, MD
  • 2-3 p.m., (473): “Danger Zone: Refractive Surgery Nightmares and Worst-Case Scenarios—A Video-Based Course,” Room 383-385, Ronald Krueger, MD
  • 4:30-5:30 p.m., (539): “Advances in Vision Restoration Techniques and Devices,” Room 388, Aleksandra Rachitskaya, MD

Tuesday, Nov. 14

  • 9-10 a.m., (621): “Advanced Corneal Topographic Analysis,” Room 393, William Dupps, MD, PhD
  • 11:30 a.m.-12:30 p.m., (660): “Case-Based Approach to Isolated Eye Pain,” Room 275-277, Gregory Kosmorsky, DO
  • 11:42-11:49 a.m., (PA102): “OCT Angiography of the Iris in Diabetic Eyes,” Room 255-257, Sunil Srivastava, MD

Trends and topics of interest

Cornea

“Identifying patients at risk of corneal ectasia is a perennial challenge in clinical cornea and refractive surgery practices. There have been important advances in this area in the past year, and several of these will be highlighted in two courses featuring Cole Eye Institute faculty focused on expert interpretation of corneal diagnostic measurements. This will also be the first meeting of the AAO after the large-scale rollout of corneal crosslinking for keratoconus in the U.S., and there are many questions about timing of treatment, optimal patient selection, and the rapidly changing situation with cost and third-party payment. These topics will be discussed during the Cornea Subspecialty Day symposium in a talk Dr. Glasser and I are presenting.”

Advertisement

Related course: “Cornea 2017: Keeping the Old, or Breaking the Mold” (Saturday, Nov. 11, 2:53-3:02 p.m., La Nouvelle Orleans AB; COR06)

Refractive surgery

“Refractive surgery in the U.S. has gone without major change for nearly a decade, but recently FDA approvals have expanded the scope of refractive surgery in several area. Topography-guided LASIK now enhances the customization of LASIK surgery beyond wavefront-guided and wavefront-optimized corrections. SMILE (small-incision lenticule extraction) surgery provides a minimally invasive method of laser vision correction with an incision much smaller than the LASIK flap, which enhances safety from trauma and dry eyes. Two different types of corneal inlays have now been approved for presbyopia correction and corneal crosslinking now helps to stabilize the refractive progression of keratoconus and ectasia.”

  • Cole Eye Institute refractive surgery specialist Ronald Krueger, MD

Related talk: “Topography Guided LASIK vs. SMILE for Laser Vision Correction,” (Sunday, Nov. 12, 2-3 p.m., Cole Eye Institute Booth 5332)

See you in New Orleans

Cole Eye Institute staff members look forward to seeing you at AAO, at our booth and at courses, lectures and symposia, and to sharing lively discussions on latest advances in eye diagnostics, treatment and research – all in our shared efforts to improve eyesight for our patients. See you there. Booth 5332.

Follow Cole Eye Institute on Twitter @CleClinicMD. Live-tweet #AAO2017 with Cleveland Clinic ophthalmologists.

Advertisement

Related Articles

OCT scan showing dry AMD
Autoimmune Disease Linked With Higher Risk of Macular Degeneration

Early data shows risk is 73% higher in patients with lupus, 40% higher in patients with rheumatoid arthritis

Closeup of an eye looking at a needle preparing to inject medication into the eyeball
Measuring the Impact of Ongoing Aflibercept Treatment in Diabetic Retinopathy

Study highlights the value of quantitative ultra-widefield angiography

Eye doctor looking into a man's eye
Faricimab Improves Results for Most Patients on Prior Therapy for nAMD

Switching medications may decrease treatment burden and macular fluid

23-EYE-4215262-CQD-Thyroid-eye-disease-tips-general-ophth-hero
Managing Thyroid Eye Disease: Insights for General Ophthalmologists

Interventions abound for active and stable phases of TED

The Featured Image for the post
November 14, 2023/Ophthalmology/News & Insight
The Art of Ophthalmic Imaging

Cole Eye Institute imaging specialists are equal parts technician, artist and diagnostician

23-EYE-4284060-CQD-Myopia-progression-children
Use Caution When Treating Myopia in Children With Intermittent Exotropia

Effect of low-dose atropine and dual-focus contact lenses is unknown in patients with comorbid eye conditions

Ad